Increased urinary metabolites oí the antiaggregatory vasodilator prostacyclin (PGI2) and the proaggregatory vasoconstrictor thromboxane A2 (TXA2) have been reported in deep vein thrombosis; however, the tissue(s) oí origin is uncertain. Because little is known about the íormation oí PGI2 or TXA2 írom its common precursor, prostaglandin (PG) endoperoxide H2 (PGH2), by varicose veins, we determined the íormation oí 6-keto-PGF la (the stable metabolite oí PGI2), TXB2 (the stable metabolite oí TXA2), andPGE2. Segments oí normal saphenousvein and varicose ve in (nine and six patients, respectively) were incubated with 10 ¡lMP4C]PGH2 íor 2 min at 37°C; products were separated by thin-Iayer chromatography. Suríace area and mass oí normal and varicose vascular segments were 19.5 :t 0.8 versus 18.8 :t 0.6 mm2 and 11.6:t 1.4 versus 10.7:t 0.7 mg, respectively. Formation oí 6-keto-PGFla and TXB2 by the segments oí varicose vein was significantly increased ayer that oí normal vein: 157 :t 14 versus 243 :t 17 pmole oí 6-keto-PGFla (P < 0.005) and 22 :t 3 versus 35 :t 5 pmole oí TXB2 (P < 0.01). The íormation oí PGE2 by segments oí varicose ve in was not significantly dift'erent írom that oí normal vein (201 :t 9 vs 219 :t 11, respectively). Deoxyribonucleic acid (DNA) content oí normal and varicose vein was 1.69:t 0.12 and 1.51 :t 0.13 mg per gram oí tissue, respectively. The data suggest that the increased PGI2 íor-mation may reflect increased activity or content oí PGI2 synthase. The increase in TXA2 íormation may reflect increased productivity or an increased presence oí residual platelets or microemboli. C) 1990 Academic Preos, Inc.
INTRODUCTION
Arachidonic acid, a 20-carbon polyunsaturated íatty acid, is a constituent oí the phospholipid component oí mammalian cell membranes. Release oí arachidonic acid írom the phospholipid pool is catalyzed by phospholipase and can result from a number of interventions including receptor-mediated events, such as stimulation by bradykinin or histamine, and non-receptor-mediated events, such as tissue injury. Prostaglandin (PG) H synthase is an enzyme found in many cell types that catalyzes the formation ofPGG2 from arachidonic acid (cyclooxygenase step), as well as the subsequent conversion of PGG2 to PGH2 (peroxidase step). PGH2 is apivotal substance that can be converted to prostacyclin (PG12), PGE2, PGD2, PGF2" , and thromboxane (TXA2). The metabolism of PGH2 is, tissue specific; however, all the metabolites of PGH2 are biologically active. Vascular tissue, both endothelíum and smooth muscle, form PG12 and have been reported to form TXA2 in small amounts, whereas the platelet principally converts PGH2 only to TXA2. Vascular formation of PG 12 and platelet-generated TXA2 are thought to be important modulators of thrombogenesis, because PG 12 is an inhibitor of platelet adhesion to the blood vessel as well as platelet aggregation, whereas TXA2 induces platelet aggregation [20] . PGE2 has been reported to produce vasodilation in the systemic vascular bed [15] and to modulate platelet aggregation [24] . We have previously demonstrated the presence of an active GSH-dependent PGH2-to-PGE2 isomerase in human saphenous ve in [16] .
The human saphenous ve in is used widely as an autologous graft in vascular surgery. 1t is used commonly in revascularization of the coronary arteries and lower limbs and for repair of traumatic arterial and venous injuries elsewhere in the body. Considerable research has focused on the physiologic mechanisms of graft patency and on the role of the eicosanoid PG12 [3, 5-7, 16, 22] . Because PG12 is produced by both intimal and subintimal regions of the vascular wall [17, 18, 26] and functions as a local vasodilator and inhibitor of platelet aggregation, it has been postulated that an increased ratio of PG 12 to the proaggregatory compound TXA2 prolongs the patency of venous grafts [6] .
Recent data have shown that PG 12 formation is augmented by increased intraluminal pressure and pulsatility of flow [5] [6] [7] , as well as stretching of the endothelial cell layer [26] . Trauma to the ve8; §#l wall alBo causes PGI2 release [14] . Moreover, increased urinary metabolites of PGI2 and TXA2, as well as increased synthesis of these two substances in hand veins, have be en reported in patients with deep venous thrombosis [23, 27] ; the tissue responsible for increased production of these substances is unknown. Thus, the literature suggests the hypothesis that there may be alterations in the metabolism of PGH2 by vascular tissue exposed to increased extraluminal pressure. The purpose of this study was to investigate the differences in eicosanoid production between normal saphenous veins and varicose saphenous veins, which are subjected to both increased pressure and stasis of blood flow.
METHODS
Normal saphenous veins were obtained from three sources: patients undergoing coronary artery bypass grafting; patients undergoing femoral-popliteal or femoral-tibial artery bypass using reversed or in situ saphenous vein; and patientsin whom the saphenous vein was used as a vein patch or interposition graft in repair of vascular trauma (Table 1) . In cardiacand trauma patients, the harvested vein was kept in iced 0.1 M potassium phosphate buffer, pH 7.4 until completion of anastomosis (15 to 60 min); leftover ve in was then placed in 0.1 M potassium phosphate buffer, pH 7.4, and frozen at -40°C for later analysis. In lower-extremity bypass patients, sections of ve in were carefully dissected at the start of the procedure and then frozen in buffer at -40°C for later analysis.
Varicose saphenous veins were obtained from patients undergoing vein stripping for removal of painful or unsightly va rico sities of the legs. Segments of varicose saphenous vein were dissected from the lower leg at the level of the ankle and frozen in buffer for later analysis;
,C the remainder of the vein removal was performed using conventional stripping wires.
RESULTS
Segments ofboth normal and varicose saphenous veinswere prepared as described in the Methods to ensure minimal differences between them with respect to mass and .n = number oí donors.
To cut precise rings, the blood vessels were laid on a movable stage beneath a razor blade guillotine and cut to provide an 18-to 20-mm2 intimal surface afea. The seg:: ments were placed in phosphate-buffer solution and warme.d to 37°C in a water bath for 2 mino The warmed segments and buffer were then added to an incubation tube containing P4C]PGH2, which had been previously blown to dryness under a stream of N2 and incubated for 2 min at 37°C while being stirred with a magnetic stir bar. The radiolabeled PGH2 was prepared from radiolabeled arachidonic acid in our laboratory using a protocol published previously [19] . The reaction was stopped and remaining substrate and radiolabeled products were then extracted by addition of ethyl acetate:methanol:0.2 M citric acid, pH 2 (15:2:1). The reaction tubes were vortexed and centrifuged at 12,000g for 30 seco The eicosanoids in the organic upper layer were separated by thin-Iayer chromatography (TLC). Products were identified by comparison with the migration of authentic standards, which were located by iodination of the chromatography plates. Radioactivity on the TLC plates was monitored by radiochromatogram scanners mated to Commodore 64 computers for data storage, analysis, and calculation. PGI2 was identified through the formation of its spontaneous breakdown product, 6-keto-PGF1a; TXA2 was identified as its breakdown product TXB2. Duplicate assays were performed on each specimen. These procedures are similar to those published previously [18] .
In another experiment, segments ofvein were prepared from the afea immediately adjacent to the segments that were incubated. These segments were analyzed for deoxyribonucleic acid (DNA) content using the method described by Fiszer-Szafarz et al. [10] .
PG formation is expressed as the mean (j: standard error of the mean) picomoles oí stable PG breakdown product formed per 2 min incubation oí PGH2. For statistical analysis, P values were calculated using Student's t test, with P < 0.05 considered statistically significant. Note. Data are expressed as means :t SEM of determinati..,n;$C ~'" on vascular segments prepared as described under Methods; n = ~",\\ of donors. P < 0.36. surface afea. The data presented in Table 2 indicate that the segments prepared from normal and varicose veins did not differ significantly from each other with respect to either of these values.
When segments of either normal or varicose vein were incubated with PGH2, the immediate precursor of both PGI2 and TXA2, both normal and varicose venous segments formed 6-keto-PGF la and TXB2 (the stable hydrolysis products of chemically unstable PG 12 and TXA2, respectively), as well as PGE2 (Table 3 ). The quantity of TXB2 produced by normal saphenous vein segments was clase to the limit of detection of the method used (i.e., 10 pmole). Statistically significant differences between the normal and varicose venous segments were observed, however, with the varicose segments producing 55% more 6-keto-PGFla (P < 0.002) and 59% more TXB2 (P < 0.03) than the normal segments. When these data were expressed as the ratio 6-keto-PG F la/TXB2, little difference was noted between the normal and varicose venous segments. No statistically significant difference was found in PGE2 formation between normal and varicose venous segments.
The DNA content of the venous segments prepared from the are a immediately adjacent to the segments, which were used to study the formation of 6-keto-PGFla and TXB2, was determined. The data in Table 4 indicate no statistically significant difference in the DNA content between segments prepared from normal or varicose human saphenous vein.
DISCUSSION
The data indicate that segments of varicose saphenous veins produce significantly more PGI2 and TXA2 from PGH2 in vitro than segments of normal saphenous veins, whereas the formation of PGE2 is similar in varicose and normal vein tissue. The vascular segments were prepared in a manner to ininimize physical differences between normal and varicose vascular segments, and the data in- With respect to TXA2 formation, the quan~-:.r=f ormed (22 :t 3 pmole) by normal saphenoU$ ~ã nd close to the limit of detection of the me~~~'.w pmole). In an earlier study, we foundthat nQ~c:.ñ ous vein did not produce detectable amoUII:!::::' = -: [ 1] . Thus, the normal saphenous vein p~ ;.~ . minimal quantity of detectable TXA2. The ~~~ ~, t~sti~ally si~nificant ~ncrease in TXB2 ~orm~:::::---~s lgn1ficant mcrease m DNA content lS ccP Note. Conditions of incubation: 0.1 Mpotassium phosphate, pH 7.4; 10 ¡tM PGH2; 37°C; 2 mino Data are expressed as picomoles of product formed and are means :t SEM of duplicate incubations of vascular segments prepared from each donar; n = number of donors.
.p < 0.005 compared with normal. ..P < 0.01 compared with normal.
the presence of a small quantity of platelets or microaggregates in the segments of varicose vein. This possibility, however, cannot be distinguished by the present data from an increase in either specific activity or quantity of TXA2 synthase as suggested for PGI2 synthase, beca use the platelet does not contain DNA. Although an .. muscle} has been reported; however, there does not appear to be such a gradient in PGI2 synthase activity [9, 18] . As such, vascular production of PGH2 from arachidonic acid is more dependent on an intact endothelium thariis the conversion of PGH2 to PGI2 [18] . Thus, in this study, the role ofthe endothelium in formation of PGI2 by normal versus varicose segments is not addressed, because PGH2, not arachidonic acid, was used as substrate. PGI2 has been shown by other investigators to have different effects on the arterial and venous systems [11, 25, 28] . While PGI2 has be en reported to be a potent arterial vasodilator, it has been reported to be without effect in the bovine intrapulmonary venous rings [12] and to produce a contractile response in both normal and varicose human saphenous vein strips [25] . If PGI2 produces a venoconstrictor response in vivo in the varicose vein, this would be potentially beneficial, because a decrease in luminal diameter could augment venous return.
More recently, Biagi et al. reported that human varicose saphenous vein produced less PGI2 and more TXA2 and PGE2 than normal saphenous vein [4] . As discussed above, we have previously demonstrated a gradient in PG 12 formation from arachidonic acid but not PGH2 by vascular segments veins. This observation is similar to that reported by Saldeen et al. [23] in that the increased synthesis of 6-keto-PGF la and TXB2 by segments of hand veins from patients with deep venous thrombosis on gentle shaking in a water bath was not associated with an altered 6-keto-PGFla/ TXB2 latía. Because PGI2 has a half-life of approximately 4 to 5 min, whereas TXA2 has a half-life of approximately 30 sec, the functional significance of the increase in PGI2 formation of an average of 86 pmole accompanied by an increase of an average of 13 pmole in TXA2 by the same vascular segment is uncertain. Although TXA2 has been suggested to be more potent on a molar basis than PGI2, no direct evidence exists [2] .
The relationship between varicose veins and increased intraluminal pressure is well established. A contributing anatomic defect is the incompetence of venous valves; whether this is the primary cause of varicose change or rather a result of the postphlebitic syndrome and dilatation is uncertain [8] . Histologically, varicose veins demonstrate variations in wall thickness, with afeas of elastic tissue degeneration and afeas of smooth muscle hypertrophy [21] . Areas of distension and aneurysmal outpouching are common. These changes combine with valvular insufficiency to allow pooling of blood in the veins, which, in turn, can promote thrombosis, edema, and venous ulceration. PGI2 acts to inhibit thrombosis and ~~9~'~'t~,~~~~~~~d'to e?S~~t"w;.,~i~Qo,~,,~t~~Q,~QP ment increased PGI2 formation [7] . These arterialized veins roughly double their basal PGI2 production, such that it approximates the basallevel of native artery. Our data indicate that the PG H2 metabolism of varicose vein segments is altered under these conditions of increased risk of thrombosis in a manner that results in increased production of both PGI2 and TXA2. PGI2 formation by varicose vein increased to levels greater than that observed previously in normal human aorta [1] . Whether this increase in PGI2 formation is a result of endothelial stretching and increased pressure or a response to Borne other signal is unknown.
With respect to endothelial PGI2 formation, PGI2 is formed by endothelial as well as vascular smooth muscle cells [17, 18] . A gradient in cyclooxygenase activity in which arachidonic acid metabolism is greatest in the intima (endothelial) compared with subintima (smooth~v ascular segments prepared from varicose human saphenous ve in produce increased amounts ofPGI2 and TXA2. The relationship between venous hypertension associated with varicose veins and increased formation of these eicosanoids requires further investigation. In addition, the physiologic significance ofthe increased formation of PGI2 and TXA2 with respect to contractile response of the vein and platelet aggregation remains to be determined.
